Nina M. Berkowitz
National Institutes of Health(US)National Institute of Allergy and Infectious Diseases(US)
Publications by Year
Research Areas
Mosquito-borne diseases and control, Malaria Research and Control, Viral Infections and Outbreaks Research, Viral Infections and Vectors, HIV Research and Treatment
Most-Cited Works
- → Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine(2013)772 cited
- → A proof of concept for structure-based vaccine design targeting RSV in humans(2019)327 cited
- → Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials(2017)300 cited
- → Chimpanzee Adenovirus Vector Ebola Vaccine(2014)281 cited
- → Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection(2017)251 cited
- → Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial(2022)157 cited
- → Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial(2014)125 cited
- → Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study(2019)125 cited
- → Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria(2022)115 cited
- → Effect of a Chikungunya Virus–Like Particle Vaccine on Safety and Tolerability Outcomes(2020)105 cited